Anzeige
Mehr »
Sonntag, 17.08.2025 - Börsentäglich über 12.000 News
Sonntag: Glencores 6,35-Mrd.-€-Deal zeigt, warum dieses 30-Mio.-€-Energie-Junior stark unterbewertet ist!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
322 Leser
Artikel bewerten:
(1)

ThinkSono Ltd: ThinkSono DVT detection software results are published in Nature digital medicine (npj)

LONDON and POTSDAM, Germany, Sept. 15, 2021 /PRNewswire/ -- A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don't have it.

ThinkSono AutoDVT App on a smartphone

DVT is a type of blood clot most commonly formed in the leg, causing swelling, pain and discomfort - if left untreated, it can lead to fatal blood clots in the lungs. 30-50% of people who develop a DVT can go on to have long-term symptoms and disability.

Researchers at Oxford University, Imperial College and the University of Sheffield collaborated with the tech company ThinkSono (which is led by Fouad Al-Noor and Sven Mischkewitz), to train a machine learning AI algorithm (AutoDVT) to distinguish patients who had DVT from those without DVT. The AI algorithm accurately diagnosed DVT when compared to the gold standard ultrasound scan, and the team worked out that using the algorithm could potentially save health services $150 per examination.

"Traditionally, DVT diagnoses need a specialist ultrasound scan performed by a trained radiographer, and we have found that the preliminary data using the AI algorithm coupled to a hand-held ultrasound machine shows promising results," said study lead Dr Nicola Curry, a researcher at Oxford University's Radcliffe Department of Medicine and clinician at Oxford University Hospitals NHS Foundation Trust.

This is the first study to show that machine learning AI algorithms can potentially diagnose DVT, and the researchers are due to start a test-accuracy blinded clinical study, comparing the accuracy of AutoDVT with standard care to determine the sensitivity of the for picking up DVT cases. The hope will be that AutoDVT will get the right diagnosis faster to the nearly 8 million people worldwide who potentially have a venous blood clot each year.

"The AI algorithm can not only be trained to analyse ultrasound images to discriminate the presence versus the absence of a blood clot - it can also direct the user using the ultrasound wand to the right locations along the femoral vein, so that even a non-specialist user can acquire the right images," said study team member Christopher Deane from the Oxford Haemophilia and Thrombosis Centre.

The research team hope that the combination of the AutoDVT tool, with the inclusion of the AI algorithm, will allow non-specialist healthcare professionals, like GPs and nurses, to quickly diagnose and treat DVT. It may additionally allow the collection of images by non-specialists which could be sent to an expert facilitating diagnosis of those unable to get to a specialist.

"Currently, many patients do not have a definitive diagnosis within 24 hours of a suspected DVT, and so many patients end up receiving painful injections of what can often be an unnecessary anticoagulant, with potential side-effect," said Dr Curry, who is also part of the Oxford Centre for Haematology.

Fouad Al Noor, the CEO of ThinkSono stated: "We are delighted by the results in this study and are excited to work further with Oxford University Hospital and other partner hospitals to trial the software and bring it to patients worldwide."

The results from the study are published in the journal npj Digital Medicine.

ThinkSono's website is found at:
www.thinksono.com

Contact ThinkSono for further information: Fouad Al Noor, hello@thinksono.com

Note: The research paper is found here at: https://www.nature.com/articles/s41746-021-00503-7 with DOI: https://doi.org/10.1038/s41746-021-00503-7

Photo - https://mma.prnewswire.com/media/1626577/ThinkSono.jpg

© 2021 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.